Literature DB >> 12426330

Impact of phosphorylation of specific residues in the tyrosine autokinase, Wzc, on its activity in assembly of group 1 capsules in Escherichia coli.

Anne Paiment1, Jennifer Hocking, Chris Whitfield.   

Abstract

Wzc(CPS) is a tyrosine autokinase essential for the assembly of a high-molecular-weight (HMW) group 1 capsular polysaccharide (CPS) in Escherichia coli. Homologues of Wzc participate in the formation of CPS and exopolysaccharides in a variety of gram-positive and gram-negative bacteria. Phosphorylation of tyrosine residues in the Wzc(CPS) C terminus is essential for HMW CPS assembly. Overexpression of Wzb(CPS) (phosphatase) in a wild-type background caused a 3.7-fold decrease in the amount of cell-associated K30 CPS produced, confirming the importance of Wzc(CPS) phosphorylation for capsule assembly. In this study, the tyrosine-rich region was dissected in an attempt to identify residues critical for Wzc(CPS) phosphorylation and/or capsule expression. Site-directed mutagenesis demonstrated that no single tyrosine residue in this region is sufficient for detectable phosphorylation of Wzc(CPS) in vivo or for HMW CPS expression. Furthermore, no single tyrosine residue is essential for phosphorylation or capsule assembly, since removal of any one tyrosine residue has no detectable effect. Altering combinations of tyrosine residues (from two to five) led to Wzc(CPS) derivatives that were still competent for phosphorylation but that could not support assembly of HMW CPS, showing that phosphorylation of Wzc per se is not an accurate measure of its ability to function in capsule assembly. One interpretation of these data is that the overall level of phosphorylation in this region, rather than the precise combination of residues accessible to phosphorylation, is important for the activity of Wzc(CPS). Tyrosine 569, a residue shown to modulate the in vitro phosphorylation of Wzc(CA) from E. coli K-12, was also mutated. The derivative with this mutation still functioned in capsule assembly. Quantitation of K30(CPS) from this mutant revealed no difference in the amount of polymer produced. Finally, dithiobis(succinimidylpropionate) cross-linking was used to confirm that Wzc(CPS) forms complexes in vivo, independent of the phosphorylation state of the protein.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12426330      PMCID: PMC135428          DOI: 10.1128/JB.184.23.6437-6447.2002

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  42 in total

Review 1.  No longer an exclusive club: eukaryotic signalling domains in bacteria.

Authors:  C J Bakal; J E Davies
Journal:  Trends Cell Biol       Date:  2000-01       Impact factor: 20.808

2.  Evaluation of Wzz/MPA1/MPA2 proteins based on the presence of coiled-coil regions.

Authors:  R Morona; L Van Den Bosch; C Daniels
Journal:  Microbiology       Date:  2000-01       Impact factor: 2.777

3.  Capsular polysaccharide is a major complement resistance factor in lipopolysaccharide O side chain-deficient Klebsiella pneumoniae clinical isolates.

Authors:  D Alvarez; S Merino; J M Tomás; V J Benedí; S Albertí
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  Translocation of group 1 capsular polysaccharide to the surface of Escherichia coli requires a multimeric complex in the outer membrane.

Authors:  J Drummelsmith; C Whitfield
Journal:  EMBO J       Date:  2000-01-04       Impact factor: 11.598

5.  Analysis of Shigella flexneri wzz (Rol) function by mutagenesis and cross-linking: wzz is able to oligomerize.

Authors:  C Daniels; R Morona
Journal:  Mol Microbiol       Date:  1999-10       Impact factor: 3.501

6.  Sequence analysis and molecular characterization of genes required for the biosynthesis of type 1 capsular polysaccharide in Staphylococcus aureus.

Authors:  W S Lin; T Cunneen; C Y Lee
Journal:  J Bacteriol       Date:  1994-11       Impact factor: 3.490

7.  Nucleotide sequence analysis of genes essential for capsular polysaccharide biosynthesis in Streptococcus pneumoniae type 19F.

Authors:  A Guidolin; J K Morona; R Morona; D Hansman; J C Paton
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

8.  Identification of cpsD, a gene essential for type III capsule expression in group B streptococci.

Authors:  C E Rubens; L M Heggen; R F Haft; M R Wessels
Journal:  Mol Microbiol       Date:  1993-05       Impact factor: 3.501

9.  Distribution of the rol gene encoding the regulator of lipopolysaccharide O-chain length in Escherichia coli and its influence on the expression of group I capsular K antigens.

Authors:  C Dodgson; P Amor; C Whitfield
Journal:  J Bacteriol       Date:  1996-04       Impact factor: 3.490

10.  Molecular, genetic, and topological characterization of O-antigen chain length regulation in Shigella flexneri.

Authors:  R Morona; L van den Bosch; P A Manning
Journal:  J Bacteriol       Date:  1995-02       Impact factor: 3.490

View more
  45 in total

1.  Mutational analysis of the carboxy-terminal (YGX)4 repeat domain of CpsD, an autophosphorylating tyrosine kinase required for capsule biosynthesis in Streptococcus pneumoniae.

Authors:  Judy K Morona; Renato Morona; David C Miller; James C Paton
Journal:  J Bacteriol       Date:  2003-05       Impact factor: 3.490

Review 2.  Myxobacteria, polarity, and multicellular morphogenesis.

Authors:  Dale Kaiser; Mark Robinson; Lee Kroos
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-07-07       Impact factor: 10.005

3.  Streptococcus pneumoniae phosphotyrosine phosphatase CpsB and alterations in capsule production resulting from changes in oxygen availability.

Authors:  K Aaron Geno; Jocelyn R Hauser; Kanupriya Gupta; Janet Yother
Journal:  J Bacteriol       Date:  2014-03-21       Impact factor: 3.490

4.  Functional analysis of Burkholderia cepacia genes bceD and bceF, encoding a phosphotyrosine phosphatase and a tyrosine autokinase, respectively: role in exopolysaccharide biosynthesis and biofilm formation.

Authors:  Ana S Ferreira; Jorge H Leitão; Sílvia A Sousa; Ana M Cosme; Isabel Sá-Correia; Leonilde M Moreira
Journal:  Appl Environ Microbiol       Date:  2006-11-17       Impact factor: 4.792

5.  Structure of Escherichia coli tyrosine kinase Etk reveals a novel activation mechanism.

Authors:  Daniel C Lee; Jimin Zheng; Yi-Min She; Zongchao Jia
Journal:  EMBO J       Date:  2008-05-22       Impact factor: 11.598

6.  Structure-function relationships of the outer membrane translocon Wza investigated by cryo-electron microscopy and mutagenesis.

Authors:  Robert C Ford; Anne L Brunkan-LaMontagne; Richard F Collins; Bradley R Clarke; Robert Harris; James H Naismith; Chris Whitfield
Journal:  J Struct Biol       Date:  2009-02-21       Impact factor: 2.867

7.  Transmembrane modulator-dependent bacterial tyrosine kinase activates UDP-glucose dehydrogenases.

Authors:  Ivan Mijakovic; Sandrine Poncet; Grégory Boël; Alain Mazé; Sylvie Gillet; Emmanuel Jamet; Paulette Decottignies; Christophe Grangeasse; Patricia Doublet; Pierre Le Maréchal; Josef Deutscher
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

8.  A novel outer membrane protein, Wzi, is involved in surface assembly of the Escherichia coli K30 group 1 capsule.

Authors:  Andrea Rahn; Kostantinos Beis; James H Naismith; Chris Whitfield
Journal:  J Bacteriol       Date:  2003-10       Impact factor: 3.490

9.  The 3D structure of a periplasm-spanning platform required for assembly of group 1 capsular polysaccharides in Escherichia coli.

Authors:  Richard F Collins; Konstantinos Beis; Changjiang Dong; Catherine H Botting; Catherine McDonnell; Robert C Ford; Bradley R Clarke; Chris Whitfield; James H Naismith
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-05       Impact factor: 11.205

10.  Crystal structures of Wzb of Escherichia coli and CpsB of Streptococcus pneumoniae, representatives of two families of tyrosine phosphatases that regulate capsule assembly.

Authors:  Gregor Hagelueken; Hexian Huang; Iain L Mainprize; Chris Whitfield; James H Naismith
Journal:  J Mol Biol       Date:  2009-07-16       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.